Skip to content 
His openness gave Parkinson’s a recognizable public face.
People who struggled to explain the condition could point to someone widely known.
Fox himself has reflected on that role.
Visibility does not cure disease.
But it can reduce isolation.
It can encourage discussion.
And it can help turn an abstract diagnosis into something the wider public understands.
Over time, Fox’s advocacy also brought researchers, donors, patients and families into the same conversation.
That community became central to the Foundation’s strategy.
Research was no longer something happening only behind laboratory doors.
Patients could participate directly.
Patients as Research Partners
One of the challenges in medical research is recruiting enough participants for clinical studies.
Parkinson’s research is no exception.
The Foundation has developed tools and programs designed to connect volunteers with research opportunities.
People with Parkinson’s can participate.
In some studies, people without Parkinson’s are also needed as comparison participants.
People with genetic risk factors may contribute to specific research.
Family members can sometimes become involved.
The larger goal is to collect enough high-quality information to understand how Parkinson’s differs from person to person.
Because one of the major lessons of modern Parkinson’s research is that the disease is not identical in everyone.
That complexity may eventually become an advantage.
Researchers increasingly hope to match treatments more precisely to different biological forms of the disease.
Genetics Became Increasingly Important
Scientists have identified multiple genetic variants associated with Parkinson’s risk.
Two of the best-known genes in Parkinson’s research are LRRK2 and GBA1.
Not everyone with Parkinson’s carries these variants.